{
  "decision": "BUY",
  "confidence": 8,
  "volatility": 12.35,
  "sharpe_ratio": 1.36,
  "reasoning": "The stock has a strong weekly performance with a favorable risk-return profile, outperforming its peers. The company's financial position is stable, with a strong profitability profile and attractive valuation. Although the debt-to-equity ratio is high, the dividend yield provides some comfort to investors. The overall news tone is neutral to positive, with a focus on pharma stocks, which supports a buy decision."
}